proteins and receptors remain limited. We recently developed ROTACs, bispecific Wnt and BMP signaling disabled
R-spondin (RSPO..., and testing in various cell-based assays for target binding and degradation efficacy. References: Sun
R, Lee H, Niehrs C (2023... -
Voir cette offre d'emploi